Memantine Hydrochloride

Overview

Memantine Hydrochloride is a medication used to treat moderate-to-severe Alzheimer's disease. It works by blocking the action of glutamate in the brain, which is believed to contribute to the symptoms of Alzheimer's.

API suppliers (16)

Suppliers of Memantine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• PROCOS SPAItaly1 active DMF GMP on record
• OLON SPAItaly1 active DMF GMP on record
• Hetero Drugs LimitedIndia1 active DMF GMP on record
• SHARON BIO MEDICINE LTDIndia1 active DMF GMP on record
• Zhejiang Supor Pharmaceuticals Co., LtdChina1 active DMF GMP on record
• WANYANG HENGSHUI PHARMACEUTICAL CO LTDChina1 active DMF
• OLPHA ASLatvia1 active DMF GMP on record
• AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPAItaly1 active DMF
• ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• ESTEVE QUIMICA SA GMP on record
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain
• TAI HENG INDUSTRY CO LTD
• Cadila Healthcare LimitedIndia
• RANBAXY LABORATORIES LTD

EU CEP holders (6)

Companies holding a valid EU Certificate of Suitability (CEP) for Memantine Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas